G-protein-activated inward-rectifying K + (GIRK) channels hyperpolarize neurons to inhibit synaptic transmission throughout the nervous system. By accelerating G-protein deactivation kinetics, the regulator of G-protein signaling (RGS) protein family modulates the timing of GIRK activity. Despite many investigations, whether RGS proteins modulate GIRK activity in neurons by mechanisms involving kinetic coupling, collision coupling, or macromolecular complex formation has remained unknown. Here we show that GIRK modulation occurs by channel assembly with R7-RGS/ Gβ5 complexes under allosteric control of R7 RGS-binding protein (R7BP). Elimination of R7BP occludes the Gβ5 subunit that interacts with GIRK channels. R7BP-bound R7-RGS/Gβ5 complexes and Gβγ dimers interact noncompetitively with the intracellular domain of GIRK channels to facilitate rapid activation and deactivation of GIRK currents. By disrupting this allosterically regulated assembly mechanism, R7BP ablation augments GIRK activity. This enhanced GIRK activity increases the drug effects of agonists acting at Gprotein-coupled receptors that signal via GIRK channels, as indicated by greater antinociceptive effects of GABA(B) or μ-opioid receptor agonists. These findings show that GIRK current modulation in vivo requires channel assembly with allosterically regulated RGS protein complexes, which provide a target for modulating GIRK activity in neurological disorders in which these channels have crucial roles, including pain, epilepsy, Parkinson's disease and Down syndrome.
Many neurotransmitters, therapeutic agents, and drugs of abuse activate metabotropic receptors coupled to the Gi/o family of heterotrimeric G proteins. These agonists modulate neuronal excitability and synaptic transmission in part by activating G-protein-activated inward-rectifying K + channels (GIRKs or Kir3s) to hyperpolarize neurons (1). The importance of this mechanism is illustrated by the diverse phenotypes exhibited by mice lacking GIRK channel subtypes, including reduced anxiety (GIRK1) (2), hyperactivity (GIRK2) (3), propensity for seizures (GIRK2) (4), and decreased morphine-mediated analgesia (GIRK2/3) (5, 6). Conversely, augmentation of GIRK activity caused by trisomic expression of the GIRK2 gene (Kcnj6) causes cognitive impairment and other phenotypes in mouse models of Down syndrome (7-9).GIRK activity is controlled in vivo by the regulator of G protein signaling (RGS) family (10-13). Regulator of G-protein signaling (RGS) proteins accelerate rates of G-protein deactivation by acting as GTPase-activating proteins (GAPs) for Gprotein α-subunits (14-16). Thus, rapid deactivation of GIRK currents requires RGS proteins because GAP activity accelerates the rate that Gi/oα subunits hydrolyze GTP and reform inactive GDP-bound Gαβγ heterotrimers.RGS proteins have been suggested to regulate GIRK gating kinetics by several mechanisms, including kinetic coupling, collisional coupling, and macromolecular complex formation with GIRK channels. Complex formation between GIRK channels ...